Cara Therapeutics
CARA
#10476
Rank
NZ$14.2 M
Marketcap
NZ$9.31
Share price
-2.56%
Change (1 day)
19.78%
Change (1 year)

Market capitalization of Cara Therapeutics (CARA)

Last known market cap: NZ$14.2 Million

As of April 2026 Cara Therapeutics has a market cap of NZ$14.2 Million. This makes Cara Therapeutics the world's 10476th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cara Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$14.2 M1.4%
2025NZ$14 M-61.91%
2024NZ$36.76 M-42.56%
2023NZ$64 M-92.96%
2022NZ$0.90 B-4.65%
2021NZ$0.95 B-8.77%
2020NZ$1.04 B-6.5%
2019NZ$1.11 B45.81%
2018NZ$0.76 B36.38%
2017NZ$0.56 B53.59%
2016NZ$0.36 B-45.5%
2015NZ$0.67 B131.4%
2014NZ$0.29 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.025 T 7,221,378.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$282.05 B 1,986,130.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
NZ$0.01 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$0.21 B 1,419.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.80 B 5,558.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.43 M-89.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ$25.52 M 79.75%๐Ÿ‡บ๐Ÿ‡ธ USA